Concurrent radiation, chemo, followed by surgery lengthens lung cancer patients survival

(ORLANDO) Patients whose lung cancer has spread to the lymph nodes have a better chance of long-term survival if they receive combined modality therapy, such as concurrent radiation and chemotherapy followed by surgery, according to a study that Loyola University Health System's Dr. Kathy S. Albain presented here today at the American Society of Clinical Oncology annual meeting.

"For patients whose lung cancer can be removed by just taking out a portion of the lung, surgery following combined chemotherapy and radiation is the best approach," said lead investigator Albain, professor, division of hematology/oncology, department of medicine, Loyola University Chicago Stritch School of Medicine, Maywood, Ill.

"If the whole lung needs to be removed, surgery may be too risky and for these patients, the best option is the combination of chemotherapy plus radiation,h said Albain, who also is director, thoracic oncology program; director, breast clinical research program; and co-director of the multidisciplinary breast oncology center, Cardinal Bernardin Cancer Center, Loyola University Health System, Maywood, Ill.

These study results are the five-year outcomes update of the National Cancer Institute-sponsored North American Lung Intergroup trial 0139. Albain serves as the medical oncology study chair for the landmark Phase III trial, the only study of its kind in the world.

Participating in the study were 396 patients with stage IIIA N2 non-small cell lung cancer (NSCLC).

Researchers divided the patients into two groups: the first group (194 patients) received concurrent chemotherapy and radiation. The second group (202 patients) received a regimen of chemotherapy and radiation followed by surgery.

Lung cancer is the leading cause of cancer deaths in men and women. NSCLC accounts for 87 percent of all diagnoses of lung cancer.

To be eligible for the study, patients had to be generally medica

Contact: Joanne Swanson
Loyola University Health System

Page: 1 2

Related biology news :

1. Committee review of stem-cell fraud finds editors followed all rules
2. Radiation therapy combined with microsurgery shows promise for curing injured spinal cord
3. Marker predicts pancreatic cancer outcome after surgery, Jefferson surgeon finds
4. Is bigger better? Breast surgery linked to boost in self-esteem and sexuality
5. Microsurgery and Super Glue show how antennae aid moth navigation
6. Successful lung cancer surgery not enough to break nicotine dependence in many smokers
7. Technology helps predict outcome of pediatric heart surgery
8. New biologic treatment for tennis elbow may replace surgery for chronic sufferers
9. OHSU eye doctor says laser surgery safer than contacts
10. Treatment disconnect in kidney cancer: Rising mortality despite more small tumors, more surgery
11. Fitness level affects bariatric surgery outcomes

Post Your Comments:

(Date:8/21/2020)... ... August 19, 2020 , ... The 19th Annual ... science, data science, informatics and IT leaders goes VIRTUAL and announces its updated ... and change, Bio-IT takes the leadership role of keeping our life science community ...
(Date:8/7/2020)... ... August 06, 2020 , ... Alucio™, ... to announce that Eric Chen and Jessica Wong have joined the company’s leadership ... Strategy, respectively. , Eric Chen heads development efforts for Alucio’s flagship product, Beacon, ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... II contract awarded by the Joint Science & Technology Office—Chemical and Biological Defense ... to develop, optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess suitable ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... , ... July 17, 2020 , ... ... consulting firm for the life sciences and food industries, is pleased to announce ... of Clinical Research – Business Development. , Charles is an accomplished and results-driven ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... therapy, today announced the hiring of Allen R. Nissenson, M.D., F.A.C.P., as its ... the clinical development of Sentien’s lead product, SBI-101. Dr. Nissenson serves as ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... procured purchasing contracts to its membership, recently named BioFit Engineered Products ... the opportunity to purchase ergonomic seating, cafeteria tables, book trucks and carts at ...
(Date:6/28/2020)... ... June 25, 2020 , ... Lumeda Inc. ... cancer, today announced the company has entered a license agreement with Roswell Park ... Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a novel medical ...
Breaking Biology Technology:
Cached News: